A COMPARATIVE-STUDY OF ANTIPYRINE AND LIGNOCAINE DISPOSITION IN NORMAL SUBJECTS AND IN PATIENTS TREATED WITH ENZYME-INDUCING DRUGS

被引：17

作者：

PERUCCA, E ^{[1
]}

HEDGES, A ^{[1
]}

MAKKI, KA ^{[1
]}

RICHENS, A ^{[1
]}

机构：

[1] ST BARTHOLOMEWS HOSP,DEPT CLIN PHARMACOL,LONDON EC1A 7BE,ENGLAND

来源：

关键词：

D O I：

10.1111/j.1365-2125.1980.tb01794.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：491 / 497

页数：7

共 46 条

[1]

ALVAN G, 1979, CLIN PHARMAC THER, V26, P327

[2]

ANDREASEN PB, 1975, CLIN PHARMAC THER, V16, P1054

[3]

BENDING MR, 1976, BR J CLIN PHARM, V3, P956

[4]

BENOWITZ N, 1974, CLIN PHARMACOL THER, V16, P87

[5]

BOYES RN, 1971, CLIN PHARMACOL THER, V12, P105

[6]

BOYES RN, 1970, J PHARMACOL EXP THER, V174, P1

[7]

BRANCH RA, 1973, J PHARMACOL EXP THER, V184, P515

[8]

BRECKENRIDGE A, 1975, ENZYME INDUCTION, P273

[9]

BREIMER DD, 1977, CLIN PHARMACOL THER, V21, P470

[10]

DANHOF M, XENOBIOTICA